$Patrys Ltd (PAB.AU)$ Delivery of GENE-EDITING constructs co...
Delivery of GENE-EDITING constructs could be very lucrative for PAB . Something not priced in the share price regarding future potential.
Comment by PAB in 2022
Patrys could also become a pioneer in the emerging gene-editing
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
